Alberta Investment Management Corp Makes New Investment in Humana Inc. (NYSE:HUM)

Alberta Investment Management Corp purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 23,840 shares of the insurance provider's stock, valued at approximately $6,048,000.

Other institutional investors also recently added to or reduced their stakes in the company. FNY Investment Advisers LLC increased its position in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after buying an additional 26,856 shares during the period. Retirement Systems of Alabama increased its position in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares during the period. PDT Partners LLC increased its position in shares of Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after purchasing an additional 2,660 shares during the period. Secure Asset Management LLC bought a new stake in shares of Humana during the fourth quarter valued at approximately $244,000. Finally, Ontario Teachers Pension Plan Board increased its position in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after purchasing an additional 71,910 shares during the period. 92.38% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.32% of the stock is currently owned by insiders.

Humana Price Performance

Humana stock traded down $17.40 on Friday, reaching $253.90. The company's stock had a trading volume of 1,942,661 shares, compared to its average volume of 1,678,572. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $30.57 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.00 and a beta of 0.56. The business's fifty day moving average price is $269.78 and its 200 day moving average price is $291.15. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.39%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Analyst Ratings Changes

A number of research firms have recently issued reports on HUM. Barclays boosted their price objective on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research report on Tuesday. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. TD Cowen upped their price target on Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.